Director/PDMR Shareholding

RNS Number : 2733M
GlaxoSmithKline PLC
14 July 2014
 



                        Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the Plan) notified the Company and the under-mentioned persons on 14 July 2014 of the following increases in their notional interests in Ordinary Shares and American Depositary Shares (ADSs) at a price of 1556.50 pence per Ordinary Share and $53.87 per ADS following the re-investment of dividends paid to shareholders on 10 July 2014.

 

Sir Andrew Witty

Acquisition of 1,790 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 1,790 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S Dingemans

Acquisition of 787 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 787 Ordinary Shares under the matching element of the Plan (Company contribution).



Dr M M Slaoui

Acquisition of 679 ADSs under the personal contribution element of the Plan.




Acquisition of 679 ADSs under the matching element of the Plan (Company contribution).



Mr S M Bicknell

Acquisition of 179 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 179 Ordinary Shares under the matching element of the Plan (Company contribution).



Mrs D P Connelly

Acquisition of 131 ADSs under the personal contribution element of the Plan.




Acquisition of 131 ADSs under the matching element of the Plan (Company contribution).



Mr R G Connor

Acquisition of 201 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 201 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S A Hussain

Acquisition of 101 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 101 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr W C Louv

 

Acquisition of 163 ADSs under the personal contribution element of the Plan.




Acquisition of 163 ADSs under the matching element of the Plan (Company contribution).



Mr D S Redfern

Acquisition of 382 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 382 Ordinary Shares under the matching element of the Plan (Company contribution).



Ms C Thomas 

Acquisition of 289 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 289 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr P C Thomson

Acquisition of 59 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 59 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr D E Troy

Acquisition of 300 ADSs under the personal contribution element of the Plan.




Acquisition of 300 ADSs under the matching element of the Plan (Company contribution).



Dr P J T Vallance

Acquisition of 839 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 839 Ordinary Shares under the matching element of the Plan (Company contribution).



Ms E Walmsley

Acquisition of 463 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 463 Ordinary Shares under the matching element of the Plan (Company contribution).

 

The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant measurement period.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

V A Whyte

Company Secretary

 

14 July 2014

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEZLFFZDFBBBK

Companies

GSK (GSK)
UK 100

Latest directors dealings